Data sharing is going on with WHO to give recognition to Bharat Biotech's Covaxin, the government said, noting that it wants to achieve this "milestone" as soon as possible.
Responding to a question on recognition of Covaxin by the WHO, NITI Aayog Member (Health) VK Paul said the government is pursuing it.
"We have been working with both Bharat Biotech and the WHO to make it happen. There is data sharing going on and we are very keen that this milestone is achieved as soon as possible. We are pursuing it," he said.
On May 24, Hyderabad-based Bharat Biotech International Limited (BBIL) conveyed to the government that it has already submitted 90 per cent of the documents to the WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine.
The latest ''Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process'' guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that "more information (is) required".
A pre-submission meeting is expected "to be planned May-June 2021", the guidance document said.
According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Indian Children Who Missed Out On Vaccines Drop To 16 lakh 2023: UN, WHO BRS Seeks Disqualification Of All 10 Defected MLAs Odisha Raj Bhavan Staffer Who Claimed Assault By Governor's Son Transferred Travel Influencer Aanvi Kamdar Dies After Falling Off A Waterfall Near Mumbai Amid Huge Row, Karnataka Pauses Bill For Reservation In Private Sector Firms Trainee IAS Summoned By Pune Cops Over Harassment Claims Against Collector West Bengal Forms Seven-Member Panel To Review New Criminal Laws US Military Declares End Of Troubled Gaza Aid Pier Mission What Is PM SHRI? Which States Resisted Centres Showcase Schools Scheme Track Latest News Live on NDTV.com and get news updates from India and around the world.